Last month, the U.S. Food and Drug Administration (the “FDA”) announced in a Declaratory Order the resolution of the shortage of semaglutide ...

By Alberto Alerigi SAO PAULO (Reuters) -Brazilian drugmaker Hypera plans to launch next year a generic version of semaglutide ...

Hypera plans to introduce a generic version of semaglutide in Brazil following patent expiration in 2026. The company is optimistic about market growth despite potential price impacts. Analysts ...

A new study has found that a once-weekly injection of semaglutide, a medication originally developed for diabetes and weight ...

The FBI has issued a warning about counterfeit versions of compounded weight loss drugs, which have been found to contain "unknown drugs, hig ...

Hims & Hers Health, Inc. stock faces volatility after an FDA halt on its GLP-1 drug. Click here to find out why HIMS stock is ...

For years, people taking GLP-1 type drugs (e.g., Ozempic, Wegovy) have noticed that the medicines didn’t just help them to ...

Injections of semaglutide were associated with significant improvement in cognitive function in people living with HIV (PWH), ...

A rise in the use of non-FDA-approved diabetes and obesity medications has spurred health care professionals and medical ...

Wegovy is a prescription medication designed for chronic weight management, offering hope to individuals struggling with ...

Weight loss can have many physical health benefits. However, it can also improve many people’s self confidence as a result of ...